Metastatic Sarcoma clinical trials

Explore recruiting metastatic sarcoma clinical trials.

Recruiting metastatic sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

GERICO14 : Randomized phase III study of oral cyclophosphamide vs doxorubicin in 65 years or older patients with advanced or metastatic soft tissue sarcoma: a UNICANCER/GERICO multicenter program

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I study evaluating the safety and efficacy of MEDI5752 in combination with stereotactic radiotherapy in patients with metastatic sarcoma

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase II study to assess the efficacy of the anti-PD-L1 antibody atezolizumab (MPDL3280A) administered with stereotactic ablative radiotherapy (SABR) in patients with metastatic tumours (SABR-PDL1)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Sarcoma trials by city

Metastatic Sarcoma in Toronto Metastatic Sarcoma in Vancouver Metastatic Sarcoma in Montreal Metastatic Sarcoma in Calgary Metastatic Sarcoma in Edmonton Metastatic Sarcoma in Ottawa Metastatic Sarcoma in Winnipeg Metastatic Sarcoma in Quebec City Metastatic Sarcoma in Hamilton Metastatic Sarcoma in Kitchener Metastatic Sarcoma in London Metastatic Sarcoma in Halifax Metastatic Sarcoma in New York Metastatic Sarcoma in Los Angeles Metastatic Sarcoma in Chicago Metastatic Sarcoma in Houston

Metastatic Sarcoma clinical trials

Recruiting metastatic sarcoma studies right now

AB122 Platform Study

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Musculoskeletal Cancers Remote Monitoring and Care

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Also recruiting in Europe

GERICO14 : Randomized phase III study of oral cyclophosphamide vs doxorubicin in 65 years or older patients with advanced or metastatic soft tissue sarcoma: a UNICANCER/GERICO multicenter program

Phase I study evaluating the safety and efficacy of MEDI5752 in combination with stereotactic radiotherapy in patients with metastatic sarcoma

A phase II study to assess the efficacy of the anti-PD-L1 antibody atezolizumab (MPDL3280A) administered with stereotactic ablative radiotherapy (SABR) in patients with metastatic tumours (SABR-PDL1)

Metastatic Sarcoma trials by city

Other conditions